Discovery of novel theophylline derivatives bearing tetrazole scaffold for the treatment of Alzheimer's disease
Nguyễn Viết Hưng,
No information about this author
Le Quoc Tien,
No information about this author
Linh Hoang Vu
No information about this author
et al.
RSC Advances,
Journal Year:
2025,
Volume and Issue:
15(9), P. 6994 - 7003
Published: Jan. 1, 2025
Alzheimer's
disease
(AD)
is
associated
with
AChE
and
BACE1
enzymes.
Designing
inhibitors
for
preventing
these
enzymes
can
be
benefit
AD
treatment.
In
this
context,
theophylline
derivatives
were
generated
to
prevent
the
biological
activity
of
BACE1.
particular,
potential
inhibitory
compounds
was
rapidly
accurately
estimated
via
knowledge-methods.
The
in
vitro
tests
then
performed
validate
artificial
intelligent
approach.
Among
these,
compound
12
exhibited
most
potent
inhibition
an
IC50
15.68
μM,
while
showing
limited
against
addition,
six
indicated
that
are
able
inhibit
AChE,
however,
play
poor
performance
over
target.
Atomistic
simulations
finally
applied
clarify
ligand-binding
mechanism
outcomes
disclose
rigidly
form
van
der
Waals
interactions
π-stacking
SC
contacts.
Overall,
may
offer
a
scaffold
novel
anti-AD
agents.
Language: Английский
Discovery of Novel DDR1 Inhibitors through a Hybrid Virtual Screening Pipeline, Biological Evaluation and Molecular Dynamics Simulations
Xinglong Chi,
No information about this author
Roufen Chen,
No information about this author
Xinle Yang
No information about this author
et al.
ACS Medicinal Chemistry Letters,
Journal Year:
2025,
Volume and Issue:
16(4), P. 602 - 610
Published: March 17, 2025
Acute
myeloid
leukemia
(AML)
is
a
heterogeneous
hematopoietic
malignancy
with
limited
therapeutic
options
for
many
patients.
Discoidin
domain
receptor
1
(DDR1),
transmembrane
tyrosine
kinase
receptor,
has
been
implicated
in
AML
progression
and
represents
promising
target.
In
this
study,
we
employed
hybrid
virtual
screening
workflow
that
integrates
deep
learning-based
binding
affinity
predictions
molecular
docking
techniques
to
identify
potential
DDR1
inhibitors.
A
multistage
process
involving
PSICHIC,
KarmaDock,
Vina-GPU,
similarity-based
scoring
was
conducted,
leading
the
selection
of
seven
candidate
compounds.
The
biological
evaluation
identified
Compound
4
as
novel
inhibitor,
demonstrating
significant
inhibitory
activity
an
IC50
46.16
nM
99.86%
inhibition
rate
against
Z-138
cells
at
10
μM.
Molecular
dynamics
simulations
free
energy
calculations
further
validated
stability
strong
interactions
DDR1.
This
study
highlights
utility
combining
learning
models
traditional
accelerate
discovery
potent
selective
compounds
hold
promise
development
targeted
therapies
AML.
Language: Английский
Tripeptides inhibit dual targets AChE and BACE-1: a computational study
RSC Advances,
Journal Year:
2025,
Volume and Issue:
15(16), P. 12866 - 12875
Published: Jan. 1, 2025
Computational
identification
of
tripeptides
as
promising
dual
AChE/BACE-1
inhibitors
for
Alzheimer's
therapy.
Language: Английский
Insights into the inhibitory activity and mechanism of natural compounds from Rhinacanthus nasutus on α-glucosidase through kinetic, molecular docking, and molecular dynamics studies
Thi‐Kim‐Dung Le,
No information about this author
Felicitas Ene,
No information about this author
Thuc‐Huy Duong
No information about this author
et al.
Journal of Molecular Structure,
Journal Year:
2024,
Volume and Issue:
unknown, P. 140527 - 140527
Published: Oct. 1, 2024
Language: Английский
Application of the Linear Interaction Energy Method to Nitric Oxide Synthase Structure-Based Inhibitor Design
Journal of Chemical Information and Modeling,
Journal Year:
2024,
Volume and Issue:
64(22), P. 8586 - 8594
Published: Nov. 7, 2024
The
overproduction
of
nitric
oxide
by
neuronal
synthase
(nNOS)
is
associated
with
several
neuropathological
conditions.
As
a
result,
inhibition
nNOS
desirable
therapeutic
goal
while
avoiding
the
endothelial
NOS
(eNOS)
given
its
essential
role
in
maintaining
cardiovascular
tone.
Designing
inhibitors
high
specificity
for
over
eNOS
challenging
close
similarity
active
site
structure
all
mammalian
isoforms.
Computational
methods
like
free
energy
perturbation
(FEP)
and
thermodynamic
integration
(TI)
offer
attractive
avenues
rational
drug
design,
but
application
these
to
hindered
challenges,
including
proper
handling
highly
charged
diverse
structures
as
well
computational
expense.
To
address
issues,
we
present
simplified
approach
combining
continuum
dielectric
generalized
born
(GB)
solvent
models
linear
interaction
(LIE)
calculations.
Our
method
demonstrates
excellent
agreement
experimental
data
targeting
isoforms
(mNOS).
results
highlight
utility
GB-LIE
promising
tool
screening
potentially
other
protein
targets
sites
inhibitor
structures.
Language: Английский